Pages that link to "Q40888180"
Jump to navigation
Jump to search
The following pages link to A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors (Q40888180):
Displaying 50 items.
- Broad-Spectrum Drugs Against Viral Agents (Q27487859) (← links)
- A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic. (Q30374413) (← links)
- PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants. (Q30381763) (← links)
- An adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza virus vaccine with antigen-sparing effect in mice (Q30390234) (← links)
- Polyarginine induces an antitumor immune response through binding to toll-like receptor 4. (Q30585455) (← links)
- Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities (Q33244320) (← links)
- Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells (Q33775637) (← links)
- Toll-like receptor agonists in cancer therapy (Q33918509) (← links)
- Immunomodulatory Effects of dsRNA and Its Potential as Vaccine Adjuvant (Q34022013) (← links)
- Toll-like receptor agonists: are they good adjuvants? (Q34067537) (← links)
- Activation of dendritic cells by the novel Toll-like receptor 3 agonist RGC100. (Q34399608) (← links)
- TLR-based immune adjuvants. (Q34400322) (← links)
- TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection (Q34807008) (← links)
- Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge (Q34855420) (← links)
- The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system. (Q35018021) (← links)
- dsRNA sensors and plasmacytoid dendritic cells in host defense and autoimmunity (Q35205757) (← links)
- Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice. (Q35484992) (← links)
- Intraperitoneal administration of poly(I:C) with polyethylenimine leads to significant antitumor immunity against murine ovarian tumors (Q36244190) (← links)
- Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor (Q36288336) (← links)
- Analysis of human blood monocyte activation at the level of gene expression. Expression of alpha interferon genes during activation of human monocytes by poly IC/LC and muramyl dipeptide (Q36349875) (← links)
- Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice (Q36403509) (← links)
- Interferon induction in primates by stabilized polyriboinosinic acid-polyribocytidylic acid: effect of component size (Q36430333) (← links)
- The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine (Q36497412) (← links)
- Toll or toll-free adjuvant path toward the optimal vaccine development (Q36763663) (← links)
- TLR agonists: our best frenemy in cancer immunotherapy (Q36850457) (← links)
- Targeting toll-like receptors for drug development: a summary of commercial approaches (Q36898653) (← links)
- TLR3 agonists and proinflammatory antitumor activities (Q37136200) (← links)
- Targeting poly(I:C) to the TLR3-independent pathway boosts effector CD8 T cell differentiation through IFN-alpha/beta (Q37177519) (← links)
- Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant (Q37273249) (← links)
- Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond (Q37286716) (← links)
- Innate sensors of influenza virus: clues to developing better intranasal vaccines (Q37298227) (← links)
- Toll-Like Receptor 3: Involvement with Exogenous and Endogenous RNA (Q37809069) (← links)
- Adjuvants for enhancing the immunogenicity of whole tumor cell vaccines. (Q37873932) (← links)
- Targeting of Toll-like receptors: a decade of progress in combating infectious diseases (Q37896347) (← links)
- Prophylactic and therapeutic implications of toll-like receptor ligands (Q37989884) (← links)
- The use of agonistic anti-CD40 therapy in treatments for cancer (Q38026924) (← links)
- Synthetic adjuvants for vaccine formulations: phytol derivatives (Q38072067) (← links)
- Modern subunit vaccines: development, components, and research opportunities (Q38073752) (← links)
- Vaccine adjuvant uses of poly-IC and derivatives (Q38259510) (← links)
- Potential approaches for more successful dendritic cell-based immunotherapy (Q38305650) (← links)
- Advances in Antiviral Therapies Targeting Toll-like Receptors (Q38733975) (← links)
- Adjuvant PIKA protects hepatoma cells from dengue virus infection by promoting a TBK-1-dependent innate immune response (Q39229727) (← links)
- Autophagy links pattern recognition receptors to tumor cell apoptosis (Q39502795) (← links)
- The interferon renaissance: molecular aspects of induction and action. (Q40100981) (← links)
- Interferons and interferon inducers: development of clinical usefulness and therapeutic promise (Q40102336) (← links)
- A novel vaccinological evaluation of intranasal vaccine and adjuvant safety for preclinical tests (Q40381324) (← links)
- Malaria vaccine adjuvants: latest update and challenges in preclinical and clinical research. (Q40752357) (← links)
- Phase I-II Trials of Poly(ICLC) in Malignant Brain Tumor Patients (Q40848933) (← links)
- Swine Influenza Virus Vaccine: Potentiation of Antibody Responses in Rhesus Monkeys (Q40880563) (← links)
- Degradation of Poly(inosinic acid) . poly(cytidylic acid) [(I)n . (Cn)] by Human Plasma (Q41554252) (← links)